Drug Discovery of Biologics Primer 101

Drug Discovery of Biologics Primer 101 is a must-have class for those new to medicines derived from living organisms. It delves deep into the five-step drug discovery process, spanning target identification and verification to candidate identification, validation, and optimization. This class reveals the utility of in silico, in vitro, and in vivo disease models in elucidating functional pharmacology activity. Drug Discovery of Biologics Primer 101 ends by demonstrating how the data analysis is used to make crucial candidate drug ‘go’ or ‘no-go’ decisions. Seize this opportunity to learn the fundamentals of biologics drug discovery. Reserve your spot now! 

Section 1: Overview

Lists the steps of the drug discovery, development and commercialization process, including activities, costs and timing generally associated with each stage.

Section 2: Early Selection, Target ID, and IgG Subtypes

Compares and contrasts properties of both small and large molecule drugs. This section also reviews antibody production, selection, and humanization. It ends with target identification processes and antibody screening considerations.

Section 3: Affinity Maturation and PharmaceuticalLiabilities

Explains antibody therapeutic classes, includes immune checkpoint inhibitors, and explains why these medications are important.

Five Takeaways


  1. List the five steps of drug discovery and state each purpose.
  2. Explain the methodologies of target identification and validation.
  3. Discuss the selection considerations for a large molecule to become a drug candidate.
  4. Describe the assays and the results needed to select a drug candidate.
  5. Explain the importance of lead candidate optimization before preclinical development.

Ready to get started?

Get in touch or enroll now

Powered By MemberPress WooCommerce Plus Integration